Insider Transactions Reported by 15 Insiders of Evommune, Inc.

Symbol
EVMN on NYSE
Location
Palo Alto, CA

Insiders trading volume in the past year

Evommune, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Isabel Verduyn van Weegen Director, 10%+ Owner $147,438,166 17 Feb 2026
7. Cooperative Ua Lsp Director, 10%+ Owner $147,438,166 17 Feb 2026
RA CAPITAL MANAGEMENT, L.P. Director $75,562,968 17 Feb 2026
Robert Lorne Hopfner Director, 10%+ Owner $63,219,381 +$17,350 +0.03% 19 Dec 2025
Luis C. Pena President & CEO, Director $11,679,544 09 Dec 2025
Eugene Bauer Chief Medical Officer, Director $4,831,393 09 Dec 2025
Janice Suzann Drew EVP, Operations $1,209,444 09 Dec 2025
Gregory S. Moss Chief Business & Legal Officer $1,147,113 09 Dec 2025
Kyle Carver Chief Financial Officer $1,115,178 09 Dec 2025
Jeegar Pravinkumar Patel Chief Scientific Officer $884,471 09 Dec 2025
Benjamin F. Mcgraw III Director 05 Nov 2025
Derek DiRocco Director 05 Nov 2025
David E. Cohen Director 07 Nov 2025
Pivotal bioVenture Partners Fund I, L.P. Director, 10%+ Owner 07 Nov 2025
Arthur S. Kirsch Director 05 Nov 2025

Recent Insider Transactions by Companies or Individuals for Evommune, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
7. Cooperative Ua Lsp EVMN Common Stock Award 7.28% 358,680 5,288,313 17 Feb 2026 See footnote
Isabel Verduyn van Weegen EVMN Common Stock Award 7.28% 358,680 5,288,313 17 Feb 2026 By LSP 7 Cooperatief U.A.
Ra Capital Management, L.P. EVMN Common Stock Award 1.34% 35,868 2,710,293 17 Feb 2026 See Footnotes
Robert Lorne Hopfner Common Stock Purchase 33% $17,350 $17.35 1,000 4,026 19 Dec 2025 By Trust
Luis C. Pena Common Stock Tax liability -4.12% -28,138 654,683 09 Dec 2025 Direct
Jeegar Pravinkumar Patel Common Stock Tax liability -13.2% -7,513 49,578 09 Dec 2025 Direct
Gregory S. Moss Common Stock Tax liability -18.3% -13,624 60,835 09 Dec 2025 Direct
Janice Suzann Drew Common Stock Tax liability -6.96% -5,074 67,794 09 Dec 2025 Direct
Kyle Carver Common Stock Tax liability -17.5% -13,290 62,510 09 Dec 2025 Direct
Eugene Bauer Common Stock Tax liability -0.54% -1,478 270,818 09 Dec 2025 Direct
Eugene Bauer Employee Stock Option (Right to Buy) Award 100,000 100,000 08 Dec 2025 Direct
Isabel Verduyn van Weegen Common Stock Purchase 46.4% 1,562,500 4,929,633 07 Nov 2025 By LSP 7 Cooperatief U.A.
Isabel Verduyn van Weegen Common Stock Conversion of derivative security 3,367,133 3,367,133 07 Nov 2025 By LSP 7 Cooperatief U.A.
Isabel Verduyn van Weegen Series C Preferred Stock Conversion of derivative security -100% -6,585,011 0 07 Nov 2025 By LSP 7 Cooperatief U.A.
Isabel Verduyn van Weegen Series B Preferred Stock Conversion of derivative security -100% -5,090,000 0 07 Nov 2025 By LSP 7 Cooperatief U.A.
Isabel Verduyn van Weegen Series A Preferred Stock Conversion of derivative security -100% -15,493,466 0 07 Nov 2025 By LSP 7 Cooperatief U.A.
Jeegar Pravinkumar Patel Common Stock Conversion of derivative security 5.89% 3,175 57,091 07 Nov 2025 Direct
Jeegar Pravinkumar Patel Series B Preferred Stock Conversion of derivative security -100% -25,000 0 07 Nov 2025 Direct
Janice Suzann Drew Common Stock Conversion of derivative security 2.23% 1,587 72,868 07 Nov 2025 Direct
Janice Suzann Drew Series B Preferred Stock Conversion of derivative security -100% -12,500 0 07 Nov 2025 Direct
7. Cooperative Ua Lsp Common Stock Purchase 46.4% 1,562,500 4,929,633 07 Nov 2025 Direct
7. Cooperative Ua Lsp Common Stock Conversion of derivative security 3,367,133 3,367,133 07 Nov 2025 Direct
7. Cooperative Ua Lsp Series C Preferred Stock Conversion of derivative security -100% -6,585,011 0 07 Nov 2025 Direct
7. Cooperative Ua Lsp Series B Preferred Stock Conversion of derivative security -100% -5,090,000 0 07 Nov 2025 Direct
7. Cooperative Ua Lsp Series A Preferred Stock Conversion of derivative security -100% -15,493,466 0 07 Nov 2025 Direct
Kyle Carver Common Stock Conversion of derivative security 4.37% 3,175 75,800 07 Nov 2025 Direct
Kyle Carver Series B Preferred Stock Conversion of derivative security -100% -25,000 0 07 Nov 2025 Direct
Gregory S. Moss Common Stock Conversion of derivative security 3,175 3,175 07 Nov 2025 By Trust
Gregory S. Moss Series B Preferred Stock Conversion of derivative security -100% -25,000 0 07 Nov 2025 By Trust
Pivotal bioVenture Partners Fund I, L.P. Common Stock Conversion of derivative security 3,367,975 1,632,441 07 Nov 2025 See footnotes
Pivotal bioVenture Partners Fund I, L.P. Series C Preferred Stock Conversion of derivative security -100% -3,135,717 0 07 Nov 2025 See footnotes
Pivotal bioVenture Partners Fund I, L.P. Series B Preferred Stock Conversion of derivative security -100% -4,000,000 0 07 Nov 2025 See footnotes
Pivotal bioVenture Partners Fund I, L.P. Series A Preferred Stock Conversion of derivative security -100% -9,812,526 0 07 Nov 2025 See footnotes
Pivotal bioVenture Partners Fund I, L.P. Series Seed Preferred Stock Conversion of derivative security -100% -10,718,463 0 07 Nov 2025 See footnotes
Eugene Bauer Common Stock Conversion of derivative security 10.5% 25,812 272,296 07 Nov 2025 Direct
Eugene Bauer Series B Preferred Stock Conversion of derivative security -100% -12,500 0 07 Nov 2025 Direct
Eugene Bauer Series Seed Preferred Stock Conversion of derivative security -100% -206,355 0 07 Nov 2025 Direct
Luis C. Pena Common Stock Conversion of derivative security 3.68% 24,225 682,821 07 Nov 2025 Direct
Luis C. Pena Series Seed Preferred Stock Conversion of derivative security -100% -206,355 0 07 Nov 2025 Direct
Robert Lorne Hopfner Common Stock Conversion of derivative security 294,502 294,502 07 Nov 2025 By Pivotal bioVenture Partners Fund II, L.P.
Robert Lorne Hopfner Common Stock Conversion of derivative security 1,632,441 1,632,441 07 Nov 2025 By Pivotal bioVenture Partners Fund I, L.P.
Robert Lorne Hopfner Common Stock Conversion of derivative security 1,441,032 1,441,032 07 Nov 2025 By NFLS Delta III Limited
Robert Lorne Hopfner Common Stock Conversion of derivative security 3,026 3,026 07 Nov 2025 By Trust
Robert Lorne Hopfner Series C Preferred Stock Conversion of derivative security -100% -2,508,575 0 07 Nov 2025 By Pivotal bioVenture Partners Fund II, L.P.
Robert Lorne Hopfner Series C Preferred Stock Conversion of derivative security -100% -313,571 0 07 Nov 2025 By Pivotal bioVenture Partners Fund I, L.P.
Robert Lorne Hopfner Series C Preferred Stock Conversion of derivative security -100% -313,571 0 07 Nov 2025 By NFLS Delta III Limited
Robert Lorne Hopfner Series B Preferred Stock Conversion of derivative security -100% -2,104,740 0 07 Nov 2025 By Pivotal bioVenture Partners Fund I, L.P.
Robert Lorne Hopfner Series B Preferred Stock Conversion of derivative security -100% -1,895,260 0 07 Nov 2025 By NFLS Delta III Limited
Robert Lorne Hopfner Series A Preferred Stock Conversion of derivative security -100% -7,230,283 0 07 Nov 2025 By Pivotal bioVenture Partners Fund I, L.P.
Robert Lorne Hopfner Series A Preferred Stock Conversion of derivative security -100% -2,582,243 0 07 Nov 2025 By NFLS Delta III Limited
* An asterisk sign (*) next to the price indicates that the price is likely invalid.